Antiviral treatment for acute retinal necrosis: A systematic review and meta-analysis.
Surv Ophthalmol
; 69(1): 67-84, 2024.
Article
de En
| MEDLINE
| ID: mdl-37774799
ABSTRACT
Acute retinal necrosis is a progressive intraocular inflammatory syndrome characterized by diffuse necrotizing retinitis that can lead to a poor visual outcome, mainly from retinal detachment. The antiviral treatment approach for acute retinal necrosis varies as there are no established guidelines. We summarize the outcomes of acute retinal necrosis with available antiviral treatments. Electronic searches were conducted in PubMed/MEDLINE, EMBASE, Scopus, and Google Scholar for interventional and observational studies. Meta-analysis was performed to evaluate the pooled proportion of the predefined selected outcomes. This study was registered in PROSPERO (CRD42022320987). Thirty-four studies with a total of 963 participants and 1,090 eyes were included in the final analysis. The estimated varicella-zoster virus and herpes simplex virus polymerase chain reaction-positive cases were 63% (95% CI 55-71%) and 35% (95% CI 28-42%), respectively. The 3 main antiviral treatment approaches identified were oral antivirals alone, intravenous antivirals alone, and a combination of systemic (oral or intravenous) and intravitreal antivirals. The overall pooled estimated proportions of visual acuity improvement, recurrence, and retinal detachment were 37% (95% CI 27-47%), 14% (95% CI 8-21%), and 43% (95% CI 38-50%), respectively. Patients treated with systemic and intravitreal antivirals showed a trend towards better visual outcomes than those treated with systemic antivirals (oral or intravenous) alone, even though this analysis was not statistically significant (test for subgroup differences P = 0.83).
Mots clés
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Décollement de la rétine
/
Infections virales de l'oeil
/
Syndrome de nécrose rétinienne aigüe
Type d'étude:
Guideline
/
Observational_studies
/
Systematic_reviews
Limites:
Humans
Langue:
En
Journal:
Surv Ophthalmol
Année:
2024
Type de document:
Article